RKLB Stock In Focus: Cantor Stays Bullish As Iridium Acquisition Funding Falls Into Place
Cantor Fitzgerald maintained its 'Overweight' rating and $122 price target for Rocket Lab (RKLB), citing its launch track record and upcoming Neutron rocket. The firm expects RKLB to generate over $900M in revenue in 2026. RKLB completed its 17th launch of 2026 and secured $1.944B in financing for its Iridium acquisition, expected to close in mid-2027. Shares traded 7% higher on Monday.
How this was made
The 30-second read
Why it matters
The funding reduces financing uncertainty, likely supporting near‑term price appreciation, while the rating upgrade adds further bullish sentiment.
Market read
Large capital raise and bullish analyst coverage provide a fresh catalyst for RKLB, making the news highly relevant for traders.
What to watch
Potential regulatory hurdles for the Iridium acquisition and execution risk of the Neutron rocket program.
Background
Rocket Lab announced a $1.944 billion ATM offering, reaffirmed its Overweight rating with a $122 price target, and noted progress on the Iridium acquisition and Neutron rocket.
Ticker impact
Rocket Lab completed a $1.944 billion ATM equity offering, providing funding for its Iridium acquisition and Neutron rocket development.
Potential upside as funding de‑riskes the acquisition and may trigger further buying on the bullish Cantor rating.
Funding of nearly $2 bn is material for a mid‑cap space company and directly addresses financing needs for a major M&A and new product, making the news actionable.
Market effects
Strengthens the commercial space sector by showing viable financing pathways for satellite operators and launch providers.
Positive for U.S. aerospace and satellite communications markets.
Highlights continued investor appetite for space infrastructure, potentially influencing peer valuations.
Counterpoint
The sizable equity dilution could pressure the stock if integration risks of Iridium materialize, suggesting caution.
Key entities
- CompanyRocket Lab
U.S. space launch provider (ticker RKLB).
- AnalystCantor Fitzgerald
Maintains Overweight rating and $122 price target for Rocket Lab.
